THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Boston Capital

The biotech bright spot

By Steven Syre
Globe Columnist / August 1, 2008

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

No one will remember this as Wall Street's summer of love. Broad market indexes were hammered in June and drifted slightly lower still in July, a trading month that mercifully concluded yesterday. Over those two months, the Standard & Poor's 500 index lost 9.5 percent of its value. (Full article: 668 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly